Immune Checkpoint Drugs May Trigger Nerve Damage in Patients Primed for Neuroinflammation
A large analysis of melanoma patients treated with immune checkpoint inhibitors finds that 12 percent develop significant neurotoxicity, often within ...
A large analysis of melanoma patients treated with immune checkpoint inhibitors finds that 12 percent develop significant neurotoxicity, often within ...
New research identifies the ion transporter SLC4A9 as a shared genetic driver of Sjögren's syndrome and amelogenesis imperfecta, linking both ...
A prospective Berlin study of 562 ischemic stroke patients finds that both high and low levels of autoantibodies targeting G ...
A new review maps how skin signs of six systemic autoimmune rheumatic diseases can flag hidden interstitial lung disease early ...
A genomic study of 841 melanoma patients at NYU Langone Health found that underrepresented minority patients experienced significantly more immune ...
A new structural study reveals how patient autoantibodies recognize the neuronal protein IgLON5, offering a molecular explanation for a rare ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine